Veterans with obesity may get healthier arteries from common diabetes pill

NCT ID NCT06745063

First seen Nov 15, 2025 · Last updated Apr 24, 2026 · Updated 21 times

Summary

This study tests whether the medication empagliflozin can make arteries more flexible in veterans with obesity. About 50 participants will take either the drug or a placebo for 12 weeks. The goal is to see if the drug improves blood vessel health, which could lower future heart risks.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OBESITY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Harry S. Truman Memorial, Columbia, MO

    RECRUITING

    Columbia, Missouri, 65201-5275, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.